Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
Stefania Gori(Ospedale Sacro Cuore Don Calabria), Guido Arcaro(Ospedale Sacro Cuore Don Calabria), Lorenzo Belluomini(University of Ferrara), Antonio Russo(University of Palermo), Paolo Bocus(Ospedale Sacro Cuore Don Calabria), Alessandro Inno(Ospedale Sacro Cuore Don Calabria), Zeno Bisoffi(University of Verona)
Cited by 164
Related Papers
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
|Diabetes Care|2007|989
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients
|Diabetes Care|2007|579
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
|Atherosclerosis|2006|555
Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease
|Nutrition Metabolism and Cardiovascular Diseases|2006|444
Insulin Causes Endothelial Dysfunction in Humans
|Circulation|2002|408